semaglutide flyer For all our Medicare folks 👋 — this upcoming GLP-1 Bridge Program may help make select weight-loss medications more affordable starting July 2026. 💉✨ semaglutide patient information leaflet resources

This catches early absorption changes After each significant weight milestone (every 10-15 pounds lost): Recheck TSH and free T4 Every 3-4 months during active weight loss phase: Full thyroid panel including TSH, free T4, free T3 After weight stabilization: Return to every 6 months for the first year, then annually if stable This is more frequent than most GLP-1 prescribers recommend for non-thyroid patients

According to the MHRA's latest guidance, while occurrences are rare, there have been reports of severe, necrotizing, and even fatal pancreatitis associated with GLP-1 and GIP receptor agonists

Given Medicares predicament across the pond, theyre unlikely to oblige

Compound Overview Class of Compound: Peptide Mechanism of Action: BPC-157 is known to stimulate vascular endothelial growth factor, which triggers the formation of blood vessels

Tirzepatide activates two receptors and produces 22.5% weight loss